[1]
S. Çokgezer, M. Şenkal, A. Safaraliyeva, S. Topuz, P. M. Saip, and N. Ak, “Real-World Survival Outcomes of Adjuvant Chemotherapy Versus Endocrine Therapy Alone in Hormone Receptor- Positive, Human Epidermal Growth Factor Receptor 2-Negative Invasive Lobular Carcinoma”, Cerrahpaşa Medical Journal, vol. 50, pp. 1–11, Jun. 2026.